In-Depth Analysis of the Endovascular Stent Grafts Market: Growth Opportunities, Key Trends, and Forecast 2025-2034

"What Are the Projected Growth and Market Size Trends for the Endovascular Stent Grafts Market?
The market size for endovascular stent grafts has seen substantial growth in recent past. The market is projected to surge from $1.05 billion in 2024 to $1.45 billion in 2025, charting a compound annual growth rate (CAGR) of 37.8%. Factors fueling this growth during the historic period include increasing occurrence of aortic aneurysms, escalating elder population, growth in healthcare expenditures in developed areas, the emergence of more ambulatory surgical centers, and an uptick in chronic disease prevalence.

The market size of endovascular stent grafts is projected to witness massive expansion in the upcoming years. It's anticipated to reach a value of $5.19 billion by 2029, with a compound annual growth rate (CAGR) of 37.6%. The anticipated rise in the forecast period can be credited to the continuous trend towards less invasive methods, a surge in vascular illnesses like atherosclerosis and pulmonary embolism, attractive reimbursement schemes, a rise in the count of hospitals, and increasing prevalence of diabetes even among the younger population. Key trends in the forecast period involve the incorporation of artificial intelligence, innovation in sophisticated imaging technologies, the creation of customizable or patient-tailored stent grafts, development of next-gen tissue-engineered vascular grafts, and advancements in technology.

What Is Driving the Growth Trajectory of the Endovascular Stent Grafts Market?
The surge in cardiovascular diseases is anticipated to fuel the expansion of the endovascular stent graft market. Cardiovascular diseases (CVD) pertain to a range of ailments affecting the heart or blood vessels. The growth in cardiovascular disease prevalence can be attributed to an amalgamation of lifestyle decisions, medical conditions, genetic predispositions, and environmental influences. Endovascular stent grafts provide a valuable treatment alternative for cardiovascular diseases, emphasizing reduced invasiveness and enhanced patient prognosis. The stent graft fortifies the compromised vessel wall, hampering it from rupturing and decreasing the probability of severe complications. For example, in December 2023, data from the Australian Institute of Health and Welfare, an Australian government agency, showed that the tally of doctor-confirmed deaths due to coronary heart disease (CHD) climbed from 14,100 in 2021 to 14,900 in 2022. Consequently, the rising incidence of cardiovascular diseases propels the endovascular stent graft market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20549&type=smp

Which Leading Companies Are Shaping the Growth of the Endovascular Stent Grafts Market?
Major companies operating in the endovascular stent grafts market are Cardinal Health Inc., Abbott Laboratories, Medtronic PLC, Stryker Corporation, Becton, Dickinson and Company (BD), Boston Scientific Corporation, Terumo Corporation, Getinge AB, Cook Group Incorporated, Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, W. L. Gore & Associates inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc. (MID), Lombard Medical Inc.

Which Leading Companies Are Shaping the Growth of the Market?
Leading entities in the endovascular stent grafts market are capitalizing on product innovation, such as thoracic aortic stent-graft development, to increase the accuracy and effectiveness of thoracic aortic aneurysms and dissections treatment. This innovation aims also to enhance patient results and tackle complex anatomical concerns with sophisticated technology and design refinement. A thoracic aortic stent graft is a distinctive medical device employed in endovascular surgery for treating thoracic aorta illnesses. The thoracic aorta is the aorta segment located in the chest that provides a balance of safety, efficiency, and expedience in handling thoracic aortic diseases. In February 2024, for example, Endovastec, a medical device firm based in China, launched the Multi-Branch Thoracic Aortic Stent-Graft System (Hector) and finished its first clinical application in Switzerland. The Hector system marks an important milestone in the progression of endovascular stent graft technology. Its multi-branch design caters to complex thoracic aortic conditions by accommodating and maintaining crucial aorta branches, like the arteries that fuel vital organs.

What Are the Key Segments of the Endovascular Stent Grafts Market?
The endovascular stent grafts market covered in this report is segmented -

1) By Product: Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts for Aorta Disease, Peripheral Vascular Grafts
2) By Raw Material: Synthetic Vascular Grafts, Biological Vascular Grafts, Hybrid Vascular Grafts
3) By Application: Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, Coronary Artery Disease

Subsegments:
1) By Hemodialysis Access Grafts: Arteriovenous (AV) Fistula Grafts, Synthetic Hemodialysis Access Grafts, Bioengineered Hemodialysis Access Grafts, Coated Hemodialysis Grafts, Endovascular Hemodialysis Grafts
2) By Endovascular Stent Grafts: Aneurysm Stent Grafts, Stent Grafts For Aortic Dissection, Thoracic Endovascular Stent Grafts, Abdominal Endovascular Stent Grafts, Biliary Endovascular Stent Grafts
3) By Coronary Artery By-Pass Grafts: Saphenous Vein Grafts (SVG), Arterial Coronary Bypass Grafts, Endovascular Coronary Artery Bypass Grafts (CABG), Synthetic Coronary Bypass Grafts
4) By Vascular Grafts For Aorta Disease: Endovascular Aortic Stent Grafts, Aortic Aneurysm Grafts, Aortic Bypass Grafts, Thoracoabdominal Aortic Stent Grafts, Aortic Dissection Stent Grafts
5) By Peripheral Vascular Grafts: Carotid Artery Stent Grafts, Femoral Artery Stent Grafts, Popliteal Artery Stent Grafts, Iliac Artery Stent Grafts, Peripheral Endovascular Stent Grafts

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/endovascular-stent-grafts-global-market-report

Which Region Dominates the Endovascular Stent Grafts Market?
North America was the largest region in the endovascular stent grafts market in 2024. The regions covered in the endovascular stent grafts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Endovascular Stent Grafts Global Market Report?

- Market Size Analysis: Analyze the endovascular stent grafts Market Size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the endovascular stent grafts market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall endovascular stent grafts market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the endovascular stent grafts market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20549

"

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
•LinkedIn: https://in.linkedin.com/company/the-business-research-company
•Twitter: https://twitter.com/tbrc_info
•YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.